Giant cell tumor of bone: Difference between revisions

Jump to navigation Jump to search
Line 70: Line 70:
===CT===
===CT===
===MRI===
===MRI===
Typical signal characteristics include:
T1
low to intermediate solid component
low signal periphery
solid components enhance, helping distinguish GCT with ABC from pure ABC 3-4
some enhancement may also be seen in adjacent bone marrow
T2
heterogenous high signal with areas of low signal intensity (variable) due to haemosiderin or fibrosis 9
if an ABC component present, then fluid-fluid levels can be seen
high signal in adjacent bone marrow thought to represent inflammatory oedema 4
T1 C+ (Gd): solid components will enhance, helping differentiate from ABCs 9
==Treatment==
==Treatment==
===Medical Therapy===
===Medical Therapy===

Revision as of 21:16, 9 March 2016

For patient information, click here Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Osteoclastoma; giant cell myeloma; giant cell tumor

Overview

Historical Perspective

Pathophysiology

Giant cell tumor of bone occurs commonly in the distal femur, the proximal tibia, the distal radius and the sacrum. Giant cell tumors (GCT) usually prefers the epiphyses of long bones.[1]

Causes

Epidemiology and Demographics

Giant cell tumor of the bone accounts for 4-5% of primary bone tumors and 18.2% of benign bone tumors [2].

Age

  • Giant cell tumor is more common in young adults between 20 and 40 years of age.

Gender

  • Giant cell tumor of bone is more common in females with the rate of growth enhanced in pregnancy.

Risk Factors

Differentiating Giant cell tumor of bone from other Diseases

A number of tumors have giant cells, but are not true benign giant cell tumors. These include

Natural History, Complications and Prognosis

Complications

Recurrence rates are higher when GCT arises at a surgical inaccessible location (e.g. spine and sacrum).

Diagnosis

Staging

History and Symptoms

  • Patients usually present with pain and limited range of motion caused by tumor's proximity to the joint space.
  • There may be swelling as well, if the tumor has been growing for a long time.
  • Some patients may be asymptomatic until they develop a pathologic fracture at the site of the tumor.

Physical Examination

Laboratory Findings

X Ray

General radiographic features include:

  • Narrow zone of transition: a broader zone of transition is seen in more aggressive giant cell tumors.
  • No surrounding sclerosis: 80-85%
  • Overlying cortex is thinned, expanded or deficient
  • Periosteal reaction is only observed in 10-30% of cases
  • Soft tissue mass is not infrequent
  • Pathological fracture may be present
  • No matrix calcification/mineralisation

On x-ray, giant cell tumors (GCTs) have a metaepiphyseal location and grow to the articular surface of the involved bone [3]. They are distinguishable from other bony tumors in that GCTs usually have a non-sclerotic and sharply defined border. Because giant cell tumors are known to metastasize, when the diagnosis of giant cell tumor is suspected, a chest x-ray or CT may be needed.

(Images courtesy of RadsWiki)

CT

MRI

Typical signal characteristics include:

T1 low to intermediate solid component low signal periphery solid components enhance, helping distinguish GCT with ABC from pure ABC 3-4 some enhancement may also be seen in adjacent bone marrow T2 heterogenous high signal with areas of low signal intensity (variable) due to haemosiderin or fibrosis 9 if an ABC component present, then fluid-fluid levels can be seen high signal in adjacent bone marrow thought to represent inflammatory oedema 4 T1 C+ (Gd): solid components will enhance, helping differentiate from ABCs 9

Treatment

Medical Therapy

Surgery

References

  1. Shrivastava, Sandeep; Nawghare, Shishir P; Kolwadkar, Yogesh; Singh, Pradeep (2008). "Giant cell tumour in the diaphysis of radius – a report". Cases Journal. 1 (1): 106. doi:10.1186/1757-1626-1-106. ISSN 1757-1626.
  2. Gamberi G, Serra M, Ragazzini P, Magagnoli G, Pazzaglia L, Ponticelli F, Ferrari C, Zanasi M, Bertoni F, Picci P, Benassi MS (2003). "Identification of markers of possible prognostic value in 57 giant cell tumors of bone". Oncology Reports. 10 (2): 351–6. PMID 12579271. Retrieved 2012-01-18.
  3. Murphey MD, Nomikos GC, Flemming DJ, Gannon FH, Temple HT, Kransdorf MJ (2001). "From the archives of AFIP. Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation". Radiographics : a Review Publication of the Radiological Society of North America, Inc. 21 (5): 1283–309. PMID 11553835. Retrieved 2012-01-18.


Template:WikiDoc Sources